Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.verified

IRWD

Price:

$3.37

Market Cap:

$549.51M

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary ch...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-02-03

Stock Exchange

NASDAQ

Ticker

IRWD

The Enterprise Value as of March 2026 (TTM) for Ironwood Pharmaceuticals, Inc. (IRWD) is 931.85M

According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 931.85M. This represents a change of 26.42% compared to the average of 737.10M of the last 4 quarters.

Ironwood Pharmaceuticals, Inc. (IRWD) Historical Enterprise Value (quarterly & annually)

How has IRWD Enterprise Value performed in the past?

The mean historical Enterprise Value of Ironwood Pharmaceuticals, Inc. over the last ten years is 1.91B. The current 931.85M Enterprise Value has changed 4.79% with respect to the historical average. Over the past ten years (40 quarters), IRWD's Enterprise Value was at its highest in in the June 2018 quarter at 3.17B. The Enterprise Value was at its lowest in in the June 2025 quarter at 621.80M.

Quarterly (TTM)
Annual

Average

1.91B

Median

1.86B

Minimum

929.01M

Maximum

2.53B

Ironwood Pharmaceuticals, Inc. (IRWD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 43.61%

Maximum Annual Enterprise Value = 2.53B

Minimum Annual Increase = -49.38%

Minimum Annual Enterprise Value = 929.01M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025929.01M-23.58%
20241.22B-49.38%
20232.40B43.61%
20221.67B-4.30%
20211.75B-8.28%
20201.91B-18.26%
20192.33B27.93%
20181.82B-27.10%
20172.50B-1.40%
20162.53B43.39%

Ironwood Pharmaceuticals, Inc. (IRWD) Average Enterprise Value

How has IRWD Enterprise Value performed in the past?

The current Enterprise Value of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.52B

5-year avg

1.59B

10-year avg

1.91B

Ironwood Pharmaceuticals, Inc. (IRWD) Enterprise Value vs. Peers

How is IRWD’s Enterprise Value compared to its peers?

Ironwood Pharmaceuticals, Inc.’s Enterprise Value is greater than Canopy Growth Corporation (157.33M), greater than Alpha Teknova, Inc. (158.74M), greater than Lifecore Biomedical, Inc. (363.71M), greater than Aurora Cannabis Inc. (310.91M), greater than BioAge Labs, Inc. (462.77M), greater than Genelux Corporation (94.74M), greater than NeuroPace, Inc. (523.51M), greater than Aldeyra Therapeutics, Inc. (-54510836746024.00), greater than Silence Therapeutics plc (314.48M), greater than Cellectis S.A. (301.48M),

CompanyEnterprise ValueMarket cap
157.33M$524.81M
158.74M$149.51M
363.71M$245.03M
310.91M$194.51M
462.77M$671.21M
94.74M$97.80M
523.51M$474.37M
-54510836746024.00$248.25M
314.48M$325.91M
301.48M$343.04M

Build a custom stock screener for Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ironwood Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?

What is the 3-year average Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?

What is the 5-year average Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD)?

How does the current Enterprise Value for Ironwood Pharmaceuticals, Inc. (IRWD) compare to its historical average?